| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles |
the Department of Physiology, University of Florida College of Medicine, Gainesville.
Correspondence to Craig H. Gelband, PhD, University of Florida College of Medicine, PO Box 100274, Gainesville, FL 32610-0274. E-mail gelband@phys.med.ufl.edu.
| Abstract |
|---|
|
|
|---|
20 mV more depolarized than the control cells. In voltage-clamp experiments with 4-aminopyridine and niflumic acid present to inhibit voltage-dependent K+ (K(v)) and Ca2+-activated Cl- (Cl(Ca)) currents, SHR and DOCA hypertensive Ca2+-activated K+ (K(Ca)) currents were significantly larger and activated at more negative potentials than the control. Conversely, with charybdotoxin and niflumic acid present to inhibit K(Ca) and Cl(Ca) currents, SHR and DOCA hypertensive K(v) current was significantly smaller than the control. Finally, basal and angiotensin IIstimulated peak intracellular free [Ca2+] was greater in the SHR and DOCA hypertensive cells compared with control cells. These results suggest that membrane potential and the activity of K(Ca) and K(v) channels are altered in hypertensive rat renal interlobar arteries and may play a role in the regulation of renal blood flow under physiological and pathophysiological conditions.
Key Words: vascular smooth muscle hypertension K+ channel membrane potential [Ca2+]i
| Introduction |
|---|
|
|
|---|
The use of fluorescent Ca2+ indicators and electrophysiological techniques has enabled studies of hypertension at the single-cell level. However, to date, the data from various models have led to differing hypotheses regarding the roles of ion channels in the regulation of [Ca2+]i and in the etiology of hypertension. For example, when SHR aortic smooth muscle cells were loaded with fura 2, basal [Ca2+]i was increased when compared with WKY cells.7 Furthermore, vasopressin-stimulated and Ang IIstimulated increases in [Ca2+]i were greater in SHR aortic cells when compared with WKY cells.8 Conversely, Storm et al9 and England et al10 showed no change in basal [Ca2+]i levels in hypertension. Using conventional microelectrodes, it was reported that the ouabain-insensitive component of resting membrane potential is 10 to 15 mV more depolarized in SHR blood vessels than in WKY vessels.11 However, other laboratories report that no change in resting membrane potential exists in hypertensive models.12 13 14 Recently, Rusch et al13 and England et al10 demonstrated that SHR aortic cells have more K(Ca) current than do WKY cells. However, no studies to date have shown alterations in K(v) current in hypertensive models. To date, the fluorescence and electrophysiological studies performed in various models of hypertension have been obtained from larger conduit arteries, which play a less significant role in setting peripheral vascular resistance than blood vessels from the kidney or mesentery. Studies of clinically relevant vessels from the renal vasculature should provide useful information concerning the electrophysiological differences in hypertension at the single-cell level. Here, we present data that for the first time demonstrate that alterations in K(v) channel activity, membrane potential, and [Ca2+]i exist in small vessels of the genetic and nongenetic hypertensive renal vasculature.
| Materials and Methods |
|---|
|
|
|---|
Electrophysiological Measurements
Single smooth muscle cells from WKY, SHR, SD, and DOCA hypertensive interlobar arteries were enzymatically dissociated using previously described methods.15 16 Care was taken to minimize trauma to either arterial preparation. Cells from normotensive and hypertensive animals were made on the same day using the same procedure, thereby ruling out nonspecific membrane effects that were due to the cell isolation technique. All experiments were conducted blind, thereby minimizing bias in the results. However, there is a possibility that the connective tissue of the arterial wall is altered in hypertension,2 causing the effectiveness of the digestive enzymes to be altered. Thus, smooth muscle cells isolated from the vessels of hypertensive rats may have been in the presence of the enzymatic digestion cocktail for longer periods of time than control cells, possibly altering sarcolemma proteins. Although difficult to test, efforts were made to reduce the possible effects of variable digestion in the tissues by examining reversibility of an Ang II (100 nmol/L)induced contraction of isolated single smooth muscle cells. Only batches of cells that showed contraction and relaxation to Ang II were used.
Single cells were voltage-clamped, and membrane currents were measured using the whole-cell configuration of the patch-clamp technique.17 Patch pipettes for whole-cell patch-clamp recordings were made from borosilicate glass capillaries and had resistances of 1 to 3 M
. Voltage-clamp command potentials were applied to the cells, and membrane currents were recorded using an Axopatch-1D patch-clamp amplifier. Membrane current was monitored on a digital oscilloscope, digitized on-line (0.5 to 2.0 kHz), and stored on a computer. Resting membrane potentials were measured in the I=0 position of the Axopatch-1D. Input resistances were determined in current clamp by applying a 1- to 5-pA hyperpolarizing current pulse and examining the change in membrane potential. Any cell that did not have a seal resistance of >5 G
was not used. Series resistance was in the range of 2 to 6 M
and was compensated for by
80% using the Axopatch-1D. Junction potentials were zeroed at the beginning of each experiment with Axopatch-1D. At the end of each experiment, no change in the nulled junction potential occurred. Data analysis was performed with pCLAMP 5.5.1 and 6.0 software (Axon Instruments). All experiments were performed at room temperature, and data illustrated in the figures were from different batches of cells isolated from different animals.
Measurement of Intracellular Ca2+
The Ca2+ indicator indo 1 (pentapotassium salt, 100 mmol/L) was included in the patch pipette solution and dialyzed into the cell as previously described.15 Background autofluorescence from the same cell was measured before gaining access to the cell interior and subtracted from all fluorescence measurements. Sufficient loading had taken place 5 to 10 minutes after access to the cell interior. A 10-mm diameter of the cell was irradiated with ultraviolet light at a wavelength of 340 nm with a mercury lamp. The light emitted from the cell was collected using an epifluorescence microscope (Nikon) and measured at 400 and 500 nm by means of a microfluorometer and matched photomultiplier tubes. Changes in [Ca2+]i were calibrated using the equation of Grynkiewicz et al18 :
![]() |
Solutions
The Krebs' solution contained (mmol/L) NaCl 120, NaHCO3 25, KCl 4.8, MgCl2 1.2, CaCl2 2.5, and D-glucose 10. For all whole-cell voltage-clamp experiments examining outward currents, the bath solution contained (mmol/L) NaCl 130, NaHCO3 10, KCl 4.2, KH2PO4 1.2, MgCl2 0.5, CaCl2 1.5, D-glucose 5.5, and HEPES 10 (pH 7.4 with NaOH). The pipette solution contained (mmol/L) KCl 140, ATP (potassium salt) 5, and HEPES 10 (pH 7.2 with KOH). Charybdotoxin was obtained from Peninsula Laboratories, Inc, and the stock was 0.1 mol/L in 150 mmol/L NaCl. All other chemicals were from Sigma Chemical Co.
Statistics
Results are expressed as mean±SEM. Statistical significance was evaluated using Student's t test for unpaired observations. Differences were considered significant at P<.05, and n corresponds to the number of cells examined. Membrane currents were measured from the zero current level and normalized to cell capacitance.
| Results |
|---|
|
|
|---|
|
Ionic Currents in WKY, SD, SHR, and DOCA Hypertensive Cells: K(v) and K(Ca) Currents
It has been reported that K(Ca) current was increased in hypertension,10 13 but to date no evidence for changes in K(v) current has been demonstrated in hypertensive models. Fig 1
shows pharmacological isolation of K(v) and K(Ca) currents from WKY and SHR cells. The use of pharmacological agents to isolate these two components of K+ current was based on experimental results obtained from the canine renal artery.15 Charybdotoxin (100 nmol/L) and niflumic acid (100 µmol/L) were used to isolate K(v) current, 4-AP (10 mmol/L) and niflumic acid (100 µmol/L) were used to isolate K(Ca) current, and 5 mmol/L ATP was present in the recording pipette to inhibit ATP-sensitive K+ current. Fig 1A
(top) shows representative ramp depolarizations from a WKY and an SHR cell in the presence of 4-AP and niflumic acid. Under these conditions, K(v) current was significantly reduced, yet K(Ca) current was present. Fig 1A
(bottom) shows the mean current-voltage relationship obtained for K(Ca) current during voltage-step depolarizations (n=7). In seven experiments, K(Ca) current in SHR cells was significantly increased when compared with control (P<.01, Table 2
). Fig 1B
illustrates the nature of K(v) current in WKY and SHR cells in the presence of charybdotoxin and niflumic acid. The top of Fig 1B
shows representative ramp depolarizations, and under these conditions, K(Ca) current was nearly abolished, yet K(v) current was present. The bottom of Fig 1B
shows the mean current-voltage relationship obtained for K(v) current during voltage-step depolarizations (n=7). In seven cells tested, K(v) current was decreased in SHR cells compared with WKY cells during voltage-step depolarizations (P<.01). Table 2
illustrates mean current density values for K(Ca) and K(v) currents in WKY and SHR cells at membrane potentials of 0 and 40 mV.
|
|
Similar results were obtained when K(v) and K(Ca) currents were isolated in control and nongenetic hypertensive cells. Fig 2
illustrates the characteristics of K(v) current in SD and DOCA hypertensive cells. During voltage-step depolarizations in the presence of charybdotoxin and niflumic acid (Fig 2A
), K(v) current in DOCA hypertensive cells is less than in control cells. During a voltage-ramp depolarization (Fig 2B
), the DOCA hypertensive cells possessed a decreased K(v) current when compared with control cells. In another set of experiments, the nature of K(Ca) current in SD and DOCA hypertensive cells was investigated (Fig 3
). Fig 3A
shows representative traces of step depolarizations from an SD and a DOCA hypertensive cell in the presence of 4-AP and niflumic acid. K(Ca) current was significantly increased in DOCA hypertensive cells compared with control cells (n=7, P<.01, Table 2
). Fig 3B
is a representative trace of K(Ca) current during voltage-ramp depolarizations in both cell types. Again, it shows that the DOCA hypertensive K(Ca) current was greater when compared with control. Fig 4
illustrates mean current-voltage relationships for K(v) and K(Ca) currents during voltage-step depolarizations in SD and DOCA hypertensive cells (n=7, P<.01). The DOCA hypertensive mean K(v) current-voltage relationship was shifted right and activated at more positive potentials than control (Fig 4A
). However, the DOCA hypertensive mean K(Ca) current-voltage relationship was shifted left and activated at more negative potentials than control (Fig 4B
). Table 2
illustrates mean current density values at 0 and 40 mV for K(Ca) and K(v) currents in SD and DOCA cells. These biophysical characteristics may be of some importance, since K+ current has been suggested to play a role in regulating resting membrane potential of vascular smooth muscle cells.15 19
|
|
|
Regulation of [Ca2+]i in WKY, SD, SHR, and DOCA Hypertensive Cells
As illustrated in Table 1
, the resting membrane potential for SHR and DOCA hypertensive artery cells was more depolarized than it was for control cells. Since [Ca2+]i has been suggested to inhibit K(v) channels and regulate membrane potential,15 a separate group of experiments was performed to investigate the regulation of [Ca2+]i in single WKY, SD, SHR, and DOCA hypertensive interlobar artery cells. Fig 5
shows that resting levels of [Ca2+]i were significantly elevated in the hypertensive cells compared with control cells (WKY, 92±7 nmol/L; SHR, 125±9 nmol/L [P<.05]; SD, 89±7 nmol/L; and DOCA, 113±11 nmol/L [P<.05]; n=6). Since circulating Ang II is a potent renal vasoconstrictor and its circulating concentration is increased in various forms of hypertension,2 we investigated the effects of Ang II on peak [Ca2+]i. Application of Ang II (100 nmol/L) significantly increased peak [Ca2+]i over basal levels in each cell type (n=6). This occurred within 5 seconds of Ang II application. A significant difference was also observed in the Ang IIstimulated increase in peak [Ca2+]i when hypertensive cells were compared with control cells (WKY, 450±25 nmol/L; SHR, 665±30 nmol/L [P<.05]; SD, 369±31 nmol/L; and DOCA, 595±20 nmol/L [P<.05]; n=6). No difference was observed in the time course of the Ang II effect in any cell type. When combined with the results of Figs 1 through 4![]()
![]()
![]()
, these data support the hypothesis that [Ca2+]i may modulate resting membrane potential by altering K(v)15 and/or K(Ca)20 current.
|
| Discussion |
|---|
|
|
|---|
Resting Membrane Potential and Hypertension
Normotensive vascular smooth muscle cells, including those isolated from the renal vasculature, have resting membrane potentials between -50 and -60 mV.13 15 16 19 29 In the present study, it was shown that SHR and DOCA hypertensive interlobar artery cells have a resting membrane potential of
-30 mV (Table 1
). This was significantly depolarized when compared with the control cells (
-50 mV). In a variety of conduit artery vascular preparations, significant changes in passive membrane electrical properties have been reported in SHR cells compared with control cells.11 12 21 29 30 However, there have been some reports of an unaltered resting membrane potential in vascular smooth muscle cells from the SHR and other models of hypertension.10 14 31 One reason for the discrepancy in resting membrane potentials may be the site and size of the vessel itself. There is ample evidence that larger capacitance vessels, like the aorta and first-branch coronary arteries, do not have similar excitation-contraction coupling properties compared with smaller resistance vessels.32 This suggests that small arteries (<200 µm in diameter) from physiologically relevant vascular beds (eg, renal, mesenteric, and cerebral) are altered in hypertension and play a significant role in the regulation of peripheral resistance.
K+ Channels and Hypertension
Membrane K+ permeability is the primary initiator of vascular smooth muscle contractility.4 5 45K+ efflux was increased in conduit artery hypertensive vascular smooth muscle compared with normotensive vascular smooth muscle.33 To date, there is no evidence that alterations in K(v) channels exist in any model of hypertension. Our results are the first to show that K(v) current was significantly reduced in SHR and DOCA hypertensive interlobar artery cells compared with control cells (Figs 1 and 3![]()
). A significant decrease of K(v) current would cause membrane depolarization and an increase in vascular smooth muscle tone. Indeed, a significant depolarization of the resting membrane potential of isolated cells from SHR and DOCA hypertensive animals was observed when compared with control cells (Table 1
). This would suggest that K(v) channels play a major role in the regulation of membrane potential and therefore tone in rat interlobar arteries.
It was previously demonstrated there was an increased K(Ca) channel and open probability of large-conductance K(Ca) channels in SHR cells isolated from the aorta.10 13 It was suggested that this enhanced K+ permeability might provide a negative-feedback mechanism by which an increased arterial contractility may be limited in hypertension.13 The data described in the present study are consistent with these conclusions. Basal [Ca2+]i is increased in the SHR and DOCA hypertensive cells (Fig 5
), and this would lead to a greater K(Ca) current density in the SHR and DOCA hypertensive cells (Figs 1 and 2![]()
). However, based on the voltage-dependent properties of this channel (ie, extremely low open probability at more negative membrane potentials), it would be difficult for this channel to be the sole channel protein that causes the increased 45K+ efflux observed in SHR arterial smooth muscle.
[Ca2+]i and Hypertension
A number of studies have attempted to compare resting levels of [Ca2+]i in SHR and WKY artery preparations.2 5 7 8 10 13 27 34 These studies have shown differing results depending mainly on the age of the animal used. In preparations of SHR arteries from young animals (3 days to 5 weeks) that have not developed hypertension, resting [Ca2+]i levels did not differ from the WKY arteries.2 5 9 However, Ang IIstimulated or vasopressin-stimulated changes in [Ca2+]i did show significant differences in young SHR, suggesting a change in Ca2+ homeostasis at an early age in development before the onset of hypertension.8 This is consistent with our results (Fig 5
). In older rats (>8 weeks), an increase in resting levels on [Ca2+]i between control and hypertensive cells was observed.7 27 However, there are studies stating that resting levels of [Ca2+]i were not altered in adult SHR vascular smooth muscle cells from conduit arteries.9 10 The present data using indo 1 fluorescence suggest that [Ca2+]i was significantly greater in SHR and DOCA hypertensive interlobar artery cells than in control cells. This increase in resting [Ca2+]i levels can be directly correlated to the changes observed in membrane potential and K(v) current. Previous results in the canine renal artery15 demonstrated the sensitivity of K(v) channels to increased [Ca2+]i, which in turn caused membrane depolarization. These data are consistent with our observations that cells from resistance blood vessels have different excitation-contraction coupling pathways and Ca2+ homeostatic mechanisms than cells from conduit blood vessels.
Ion Channel Control of Vascular Smooth Muscle Tone in Hypertension
Recently, a number of K+ channels have been suggested to regulate membrane potential and tone of smooth muscle cells. It has been demonstrated that voltage-dependent delayed rectifier K+ channels are important regulators of smooth muscle resting membrane potential.15 19 This is consistent with our observations in the interlobar artery smooth muscle cells. Our results in clinically relevant resistance vessels suggest that the inhibition of the K(v) channel and the associated membrane depolarization would be of physiological importance in the regulation of tone in normotensive and hypertensive states.15 However, other K+ channels have also been suggested to play a role in the regulation of smooth muscle tone. Large-conductance K(Ca) channels may represent a negative-feedback mechanism for cerebral arteries when pressurized.34 ATP-sensitive35 and inwardly rectifying K+ channels36 also have been implicated in regulating tone in the small vessels of cerebral, pulmonary, and coronary circulation. Therefore, a combination of K+ channels or variation in K+ channel distribution may explain why different K+ channels are observed to regulate membrane potential in various vascular beds.
Significance of the Kidney in Hypertension
Despite years of intensive investigation, the etiology of hypertension remains unknown. Elevated blood pressure and total peripheral resistance associated with hypertension may result from increases in neural, humoral, or vasoconstrictor substances, passive or genetic structural alterations in blood vessels, or intrinsic changes in the control of vascular tone. The interlobar artery of the kidney is a significant blood vessel to study, since alterations in renal blood flow are known to influence fluid volume regulation, the secretion of a number of important neurohumoral substances, and arteriolar resistance, which may be involved in the etiology or maintenance of hypertension. However, direct measurements of the major ionic conductances that may underlie contraction of hypertensive rat interlobar arterial smooth muscle are lacking. This is rather remarkable given the results of earlier renal transplant studies in humans37 38 and animals,39 which suggested that the genetic defect in a proportion of the cases with essential hypertension is expressed in the kidney. In these studies, kidney transplants from normotensive donors into hypertensive recipients effectively reversed many of the abnormalities associated with hypertension. In summary, the data demonstrate that the alterations in resting membrane potential observed in the SHR and DOCA hypertensive interlobar artery could be manifested through alterations in one or a combination of K(v) channels or K(Ca) channels. These alterations in ionic conductances may play a role in the etiology and/or maintenance of the hypertensive state.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received February 2, 1996; accepted May 6, 1996.
| References |
|---|
|
|
|---|
2. Khalil RA, Lodge NJ, Saida K, Gelband CH, van Breemen C. Calcium mobilization in vascular smooth muscle and its relevance to the etiology of hypertension. In: Laragh JM, Brenner BM, eds. Hypertension, Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Publishers; 1990:547-563.
3.
Lamb FS, Volk KA, Shibata EF. Calcium-activated chloride current in rabbit coronary artery myocytes. Circ Res. 1994;75:742-750.
4.
Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990;259:C3-C18.
5.
Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
6. Pacaud P, Loirand G, Lavie JL, Mironneau C, Mironneau J. Calcium-activated chloride current in rat vascular smooth muscle cells in short term primary culture. Pflugers Arch. 1989:413:629-636.
7. Sugiyama T, Yoshizumi M, Takaku F, Urabe H, Tsukakoshi M, Kasuya T, Yazaki Y. The elevation of the cytoplasmic calcium ions in vascular smooth muscle cells in SHRmeasurement of the free calcium ions in single living cells by lasermicrofluorospectrometry. Biochem Biophys Res Commun. 1986;141:340-345.[Medline] [Order article via Infotrieve]
8. Nabika T, Velletri PA, Beaven MA, Endo J, Lovenberg W. Vasopressin-induced calcium increases in smooth muscle cells from spontaneously hypertensive rats. Life Sci. 1985;37:579-584.[Medline] [Order article via Infotrieve]
9.
Storm DS, Stuenkel EL, Webb RC. Calcium channel activation in arterioles from genetically hypertensive rats. Hypertension. 1992;20:380-388.
10.
England SK, Wooldridge TA, Stekeil WJ, Rusch NJ. Enhanced single-channel K+ current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993;264:H1337-H1345.
11.
Hermsmeyer K. Electrogenesis of increased norepinephrine sensitivity of arterial vascular muscle in hypertension. Circ Res. 1976;38:362-367.
12. Lamb FS, Webb RC. Regenerative electrical activity and arterial contraction in hypertensive rats. Hypertension. 1989;13:70-76.[Abstract]
13.
Rusch NJ, De Lucena RG, Wooldridge TA, England SK, Cowley AW Jr. A Ca2+-dependent K+ current is enhanced in arterial membranes of hypertensive rats. Hypertension. 1992;19:301-307.
14. Steikel WJ. Electrophysiological mechanisms of force development by vascular smooth muscle membrane in hypertension. In: Lee RMKW, ed. Blood Vessel Changes in Hypertension. Boca Raton, Fla: CRC Press; 1989:127-170.
15.
Gelband CH, Hume JR. [Ca2+]i inhibition of K+ channels in canine renal artery: novel mechanism for agonist-induced membrane depolarization. Circ Res. 1995;77:121-130.
16.
Gelband CH, Hume JR. Ionic currents in single smooth muscle cells of the canine renal artery. Circ Res. 1992;71:745-758.
17. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.[Medline] [Order article via Infotrieve]
18. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;200:3440-3450.
19.
Fleischmann BK, Washbau RJ, Kotlikoff MI. Control of resting membrane potential by delayed rectifier potassium currents in ferret airway smooth muscle cells. J Physiol (Lond). 1993;469:625-638.
20. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 1992;256:532-535.
21.
Tomobe Y, Ishikawa T, Yanagisawa M, Kimura S, Masaki T, Goto K. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscle cells of spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther. 1991;257:555-561.
22.
Van de Voorde J, Vanheel B, Leusen I. Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ Res. 1992;70:1-8.
23.
Ohya Y, Abe I, Fujii K, Takata Y, Fujishima M. Voltage-dependent Ca2+ channels in resistance arteries from spontaneously hypertensive rats. Circ Res. 1993;73:1090-1099.
24.
Rusch NJ, Hermsmeyer K. Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats. Circ Res. 1988;63:997-1002.
25.
Wilde DW, Furspan PB, Szocik JF. Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension. 1994;24:739-746.
26. Bukoski RD. Intracellular Ca2+ metabolism of isolated resistance arteries and cultured vascular myocytes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. J Hypertens. 1990;8:37-43.[Medline] [Order article via Infotrieve]
27. Losse H, Zidek W, Vetter H. Intracellular sodium and calcium in vascular smooth muscle of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1984;6:S32-S37.
28.
Papageorgiou P, Morgan KG. Intracellular free Ca2+ is elevated in hypertrophic aortic muscle from hypertensive rats. Am J Physiol. 1991;260:H507-H515.
29.
Harder DR, Hermsmeyer K. Membrane mechanism in arterial hypertension. Hypertension. 1993;5:404-408.
30. Harder DR, Brann L, Halpern W. Altered membrane electrical properties of smooth muscle cells from small cerebral arteries of hypertensive rats. Blood Vessels. 1983;20:154-160.[Medline] [Order article via Infotrieve]
31. Abel PW, Trapani A, Matsuki N, Ingram MJ, Ingram FD, Hermsmeyer K. Unaltered membrane properties of arterial muscle in Dahl strain genetic hypertension. Am J Physiol. 1981;241:H224-H227.
32. van Breemen C, Saida K. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol. 1989;51:315-329.[Medline] [Order article via Infotrieve]
33.
Jones AW. Altered ion transport in vascular smooth muscle from spontaneously hypertensive rats. Circ Res. 1973;33:563-572.
34.
Erne P, Hermsmeyer K. Intracellular vascular muscle Ca2+ modulation in genetic hypertension. Hypertension. 1989;14:145-151.
35.
Clapp LH, Gurney AM. ATP-sensitive K+ channels regulate resting potential of pulmonary arterial smooth muscle cells. Am J Physiol. 1992;262:H916-H920.
36.
Quayle JM, McCarron JG, Brayden JE, Nelson MT. Inward rectifying K+ currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol. 1993;265:C1363-C1370.
37. Bianchi G, Gatt M, Ferrari P, Picotti G, Colombo G. A renal abnormality as a possible cause of `essential' hypertension. Lancet. 1979;109:173-177.
38. Curtis J, Luke R, Dustan H, Kashgarian M, Whelchel J. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309:1009-1015.[Abstract]
39.
Dahl L, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure. Circ Res. 1974;34:94-101.
This article has been cited by other articles:
![]() |
S. Sonkusare, M. Fraer, J. D. Marsh, and N. J. Rusch Disrupting Calcium Channel Expression To Lower Blood Pressure: New Targeting of a Well-Known Channel Mol. Interv., December 1, 2006; 6(6): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, W. F. Jackson, G. D. Fink, and J. J. Galligan Activation of Potassium Channels by Tempol in Arterial Smooth Muscle Cells From Normotensive and Deoxycorticosterone Acetate-Salt Hypertensive Rats Hypertension, December 1, 2006; 48(6): 1080 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ardanaz and P. J. Pagano Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Bratz, G. M. Dick, L. D. Partridge, and N. L. Kanagy Reduced molecular expression of K+ channel proteins in vascular smooth muscle from rats made hypertensive with N{omega}-nitro-L-arginine Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1277 - H1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Bratz, A. N. Swafford Jr., N. L. Kanagy, and G. M. Dick Reduced functional expression of K+ channels in vascular smooth muscle cells from rats made hypertensive with N{omega}-nitro-L-arginine Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1284 - H1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hebert, G. Desir, G. Giebisch, and W. Wang Molecular Diversity and Regulation of Renal Potassium Channels Physiol Rev, January 1, 2005; 85(1): 319 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pesic, J. A. Madden, M. Pesic, and N. J. Rusch High Blood Pressure Upregulates Arterial L-Type Ca2+ Channels: Is Membrane Depolarization the Signal? Circ. Res., May 28, 2004; 94(10): e97 - e104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fountain, A. Cheong, R. Flemming, L. Mair, A. Sivaprasadarao, and D. J. Beech Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle J. Physiol., April 1, 2004; 556(1): 29 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Amberg, S. D. Koh, Y. Imaizumi, S. Ohya, and K. M. Sanders A-type potassium currents in smooth muscle Am J Physiol Cell Physiol, March 1, 2003; 284(3): C583 - C595. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Bratz, R. Falcon, L. D. Partridge, and N. L. Kanagy Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1648 - H1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Wellman, L. Cartin, D. M. Eckman, A. S. Stevenson, C. M. Saundry, W. J. Lederer, and M. T. Nelson Membrane depolarization, elevated Ca2+ entry, and gene expression in cerebral arteries of hypertensive rats Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2559 - H2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mohanty, M. Ye, X. Li, and N. F. Rossi Hypotonic swelling-induced Ca2+ release by an IP3-insensitive Ca2+ store Am J Physiol Cell Physiol, August 1, 2001; 281(2): C555 - C562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Cheong, A M Dedman, and D J Beech Expression and function of native potassium channel (KV{alpha}1) subunits in terminal arterioles of rabbit J. Physiol., August 1, 2001; 534(3): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Sobey Potassium Channel Function in Vascular Disease Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 28 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Clark and L. C. Fuchs BKCa channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2598 - H2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Seiden, O. Platoshyn, A. E. Bakst, S. S. McDaniel, and J. X.-J. Yuan High K+-induced membrane depolarization attenuates endothelium-dependent pulmonary vasodilation Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L261 - L267. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Jackson Ion Channels and Vascular Tone Hypertension, January 1, 2000; 35(1): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gelband, H. Wang, M. L. Gardon, K. Keene, D. S. Goldberg, P. Y. Reaves, M. J. Katovich, and M. K. Raizada Angiotensin I-Converting Enzyme Antisense Prevents Altered Renal Vascular Reactivity, but Not High Blood Pressure, in Spontaneously Hypertensive Rats Hypertension, January 1, 2000; 35(1): 209 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gelband, P. Y. Reaves, J. Evans, H. Wang, M. J. Katovich, and M. K. Raizada Angiotensin II Type 1 Receptor Antisense Gene Therapy Prevents Altered Renal Vascular Calcium Homeostasis in Hypertension Hypertension, January 1, 1999; 33(1): 360 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H M Prior, M S Yates, and D J Beech Functions of large conductance Ca2+-activated (BKCa), delayed rectifier (KV) and background K+ channels in the control of membrane potential in rabbit renal arcuate artery J. Physiol., August 15, 1998; 511(1): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, A. G. Hudetz, H.-G. Knaus, and N. J. Rusch Increased Expression of Ca2+-Sensitive K+ Channels in the Cerebral Microcirculation of Genetically Hypertensive Rats : Evidence for Their Protection Against Cerebral Vasospasm Circ. Res., April 6, 1998; 82(6): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Yuan, J. Wang, M. Juhaszova, V. A. Golovina, and L. J. Rubin Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L621 - L635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Martens, P. Y. Reaves, D. Lu, M. J. Katovich, K. H. Berecek, S. P. Bishop, M. K. Raizada, and C. H. Gelband Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy PNAS, March 3, 1998; 95(5): 2664 - 2669. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, K. Pleyte, H.-G. Knaus, and N. J. Rusch Increased Expression of Ca2+-Sensitive K+ Channels in Aorta of Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1403 - 1409. [Abstract] [Full Text] |
||||
![]() |
C. H. Gelband and H. Gelband Ca2+ Release From Intracellular Stores Is an Initial Step in Hypoxic Pulmonary Vasoconstriction of Rat Pulmonary Artery Resistance Vessels Circulation, November 18, 1997; 96(10): 3647 - 3654. [Abstract] [Full Text] |
||||
![]() |
H.-Y. Sohn, M. Keller, T. Gloe, H. Morawietz, U. Rueckschloss, and U. Pohl The Small G-protein Rac Mediates Depolarization-induced Superoxide Formation in Human Endothelial Cells J. Biol. Chem., June 16, 2000; 275(25): 18745 - 18750. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |